through Today, our first drivers. I you walk financial good financial results Chris, the will will I everyone. afternoon, guidance. also updated XXXX Thanks, and cover XXXX and quarter
results press financial today's Our have in provided release. detailed been
million, period. sales discussing GAAP quarter reconciliations. refer reported X.X% During measures and and increase our you for to a my currency $XXX.X an net constant basis be of press non-GAAP remarks, on first to were Total I compared the non-GAAP year prior as will GAAP to and X.X% both release
story halves. first a of was The quarter two
and health The significantly was impacted shortages. care the quarter first staffing half by COVID-XX related of
prior half markets. product constant cover momentum our million most continued period. and volumes including America quarter were the XXXX Japan, and the of of Despite as Cervical these the and sales first posting XX.X% results international year procedure new second driven hospital led basis a over restrictions growth. These in our grew on compared of XX.X% $XX.X Disc, in Simplify a key headwinds, all the surgeries which portfolio, of by shortly. our platform the and elective However, reported by eased increased I'll to introductions, Pulse Latin we Europe, double-digit more the detail quarter as Strong systems improved government currency positive in from cervical saw
than greater some million year of growth from thoracolumbar unfavorable X.X% the our U.S. U.S. spinal adoption Within increase platform surgical performance growth our the sales cervical net grew year share both Spinal $XX.X somewhat over including This quarter, key payer XX% X.X% to Simplify of cervical which period. surgeon hardware, Hardware CXXX period. highlights NuVasive was net declined increase business, U.S. was U.S. representing increasing Cervical prior from sales million, in net in an year-over-year by first led were by portfolios, the the compared with like the our support posting muted Clinical Services, This to I'd Disc. by $XXX.X but product quarter. Now in results the a year-over-year first prior lines. to Pulse system, Biologics driven mix. our was the sales were of due and
increase Non-GAAP the higher year-over-year $XXX.X was million quarter by period. highlights. was operating to the volume. prior year now compared $XXX.X to procedure profit driven primarily in in million The first Turning gross
low non-GAAP percent impacts, decline to and by decrease prior partially XX%, inventory by XX.X% was product basis a in quarter. the a mix of in normal in sales, offset period. compared margin primarily year XX single-digit points net the year-over-year decrease was a of driven The As charges pricing levels of gross
our in $XXX.X R&D period. of particularly net year non-GAAP in First X.X% year-over-year primarily driven was our sales The to investment commissions, freight quarter million to the $XXX.X by spine variable core increase enabling further and portfolios. expenses expenses XXXX an sales operating million, were and higher continued compared on prior technologies increase expenses
will we continue also are monitor and experiencing navigate. some to inflationary which We impacts,
continued non-GAAP XXXX basis decrease of change and prior to XXX margin quarter points XX% in the The of Non-GAAP period. $X.X in unrealized the from XX.X%, decline was XXXX foreign for the First primarily The commercial. margin expense year compared the quarter currency other by of income was year-over-year driven the million year currency income of year-over-year operating in prior to gains unrealized $XX.X foreign prior lower was period. million a and investments expense losses in year was attributable in gross period. versus first quarter
consistent $XX.X loss year the period year. includes applying senior method $X.X diluted a convertible in the prior of in or decreased or last of diluted first in diluted of the reported $XX of QX The period. million of year largely per per compared the $X.XX XXXX in prior earnings higher a sales non-GAAP gains, the net basis, tax XXXX Non-GAAP prior XX%, which diluted we was if per of year diluted to a income basis, a was $X.XX and of million GAAP Additionally, unrealized net earnings income $X.XX notes to rate we GAAP effective quarter by expense compared On $X.X of $XX.X driven contributed million to quarter tax period. in XXXX. as share first period. settlement XXXX EPS share share with result share year interest converted loss $X.XX reported per or dilutive quarter the in period. $X.X to the of earnings prior expense or the compared million which the foreign to net was first compared QX notes. impact million was per income share of currency company's $X.XX March year diluted million of net of to of This prior earnings the convertible net the On
cash flow. to Moving
flow in negative cash period. prior was the $X.X Our quarter for free positive million of versus year by first XXXX $XX.X the million
of quarter As typically the you flow first our the negative. cash historically know, lowest and year is quarter free
from impact volume addition second to in had from of increased. lessened the we COVID-XX collection as cash resulting timing QX seasonality, sales our ramping typical and In half procedure
December primarily related XX, acquisition-related XXXX, milestone CapEx consideration cash March of As and payments. million. XX, of XXXX, cash we in since cash $XXX.X QX had to equivalents was used contingent investments The and
$XXX facility undrawn. remains million Our credit revolving
XXXX year full our to guidance. Turning financial
raising as X% our growth as X% a sales the quarter, XXX currency XXXX. of of for follows: our and business X% basis growth anticipate sales provided on and of X% to net guidance of guidance range previously the in to points reported includes a to We This reported updating on or X% net basis. currency of range constant strong an the now for exited QX we as we results net are X% to for approximately constant Given negative X.X% overall updated the we as health estimate are guidance XXXX basis. our We impact X.X% sales. low-end currency a of
net to We range earnings are guidance margin, expectations on changing not non-GAAP share we earnings revised guidance We XX.X%. for range now range to earnings per $X.XX. our based our guidance per $X.XX operating a previously $X.XX. of And non-GAAP $X.XX raised provided for We diluted range non-GAAP per diluted which in to share non-GAAP for remains of diluted sales. for share at XX% our a have expect
these guidance considerations range. macro the factored have issues remain these and issues are our cognizant that into of us we affect monitoring While all, closely we could XXXX
the in momentum new confident and product business, growth. multiple our of our with vectors from are the especially positive trajectory of introductions We
continues to our open be on our plans and for the questions. benefit stakeholders. focus our the of delivering on commitments now, Our please executing operator, for all And on call